Telithromycin Pharmacokinetics in Rat Model of Diabetes Mellitus Induced by Alloxan or Streptozotocin
Authors:
- 14 May 2008
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 25 (8) , 1915-1924
Abstract
It has been reported that telithromycin is primarily metabolized via hepatic CYP3A1/2 in rats, the expression and/or mRNA level of hepatic CYP3A1/2 increase in rat model of diabetes mellitus induced by alloxan (DMIA) or streptozotocin (DMIS), and intestinal CYP3A1/2 enzyme activity decreases in rat model of DMIS. Thus, the pharmacokinetic changes of telithromycin in both models of diabetes mellitus compared with those in the control rats were evaluated.Keywords
This publication has 33 references indexed in Scilit:
- Effects of acute renal failure on the pharmacokinetics of telithromycin in rats: negligible effects of increase in CYP3A1 on the metabolism of telithromycinBiopharmaceutics & Drug Disposition, 2007
- Inhibition of Translation and 50S Ribosomal Subunit Formation in Staphylococcus aureus Cells by 11 Different Ketolide AntibioticsCurrent Microbiology, 1998
- Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetesBiochemical Pharmacology, 1993
- Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutritionJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Fluid Shifts and Other Factors Affecting Plasma Protein Binding of Prednisolone by Equilibrium DialysisJournal of Pharmaceutical Sciences, 1984
- Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolismJournal of Pharmacokinetics and Biopharmaceutics, 1983
- Comparison of Equilibrium Times in Dialysis Experiments Using Spiked Plasma or Spiked BufferJournal of Pharmaceutical Sciences, 1982
- Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curveJournal of Pharmacokinetics and Biopharmaceutics, 1978
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- A physiological approach to hepatic drug clearanceClinical Pharmacology & Therapeutics, 1975